News Release
  October 10, 2012

CONTACT:

Karen Kreeger

215-349-5658
karen.kreeger@uphs.upenn.edu

Perelman School of Medicine


This release is available online at
http://www.uphs.upenn.edu/news/News_Releases/2012/10/itmat/

Penn Translational Medicine Institute to Hold 7th Annual Symposium

The  Institute for Translational Medicine and Therapeutics’ 7th Annual International Symposium (ITMAT) will be held October 16 and 17 at the Perelman School of Medicine, University of Pennsylvania. This unique gathering brings together international experts to debate opportunities and hazards in systems pharmacology and translational medicine, or how drugs work on specific pathways, variability in patient response and why many treatments fail.  Thought leaders from academic medical centers and industry will be speaking on topics including, Global Approaches to Translational Medicine, Translational Therapeutics, The Individualization of Therapy and Systems Pharmacology.

Garret A. FitzGerald, Director of ITMAT, will be hosting the event. The talks include:

  • David Artis, PhD, Perelman School of Medicine, Department of Microbiology University of Pennsylvania, Translating Immunology: New Insights into the Pathogenesis and Treatment of Chronic Inflammatory Diseases in Humans
  • Carl June, MD, Perelman School of Medicine, University of Pennsylvania, Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Engineered T cells: muscle CARs and sports CARs for Cancer
  • Hal Dietz, MD, Johns Hopkins University School of Medicine, will be presenting Found in Translation: New Insights into the Pathogenesis and Treatment of Marfan Syndrome and Related Disorders
  • Peter Schultz, PhD, Department of Chemistry, The Scripps Research Institute, will be speaking on A Chemist’s Foray into Translational Research
  • Matthias Mann, Director, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany, will be presenting Proteomics for Systems-Wide Approaches in Cell Line, Animal and Human Systems

The full agenda and list of speakers can be found on ITMAT’s website. There will also be opportunities to meet and speak with presenters and fellow attendees, which will include academics and industry executives.

 Registration is required for attendance, and there is also an option to participate via web. Please contact me to register as a reporter for this event or to view on the web.

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.